Writer: Rory Appleton, [email protected] For more news, visit the IU School of Medicine Newsroom: medicine.iu.edu/news
Here's what you should know going in: Commonly reported effects include nausea, vomiting, diarrhea, and constipation, particularly during initial dose escalation Warnings and precautions in the prescribing information for applicable semaglutide and tirzepatide products cover pancreatitis, gallbladder disease, and kidney injury associated with volume depletion If you're on insulin or sulfonylureas, discuss hypoglycemia risk with your prescriber - GLP-1 medications can affect blood sugar control when combined with those drugs These medications slow gastric emptying, which can affect how orally taken medications are absorbed - worth flagging if you take other oral drugs regularly Certain FDA-approved semaglutide and tirzepatide products carry a boxed warning concerning thyroid C-cell tumors observed in rodents
Tirzepatide, with its demonstrated ability to produce 20+ percent weight loss, reaches into territory that phentermine cannot approach
If your vial does not clearly state the concentration, do not guess
This young man is the CEO of a medical and health group company in Hong Kong, which holds a license as a pharmaceutical trader in Hong Kong and is the leading distributor of Novo Nordisk's Semaglutide oral tablets and Eli Lilly's Tirzepatide injection